| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Germany | 4 | |
| #2 | EPO (European Patent Office) | 4 | |
| #3 | Canada | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | Australia | 1 | |
| #6 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Horowski Reinhard | 10 |
| #2 | Tack Johannes | 10 |
| #3 | Kranda Karel | 7 |
| #4 | Bostedt Katalin Tisa | 4 |
| #5 | Sonka Karel | 4 |
| #6 | Schenk Dirk | 4 |
| #7 | Engfer Adalbert | 4 |
| #8 | Cvak Jan | 3 |
| #9 | Glusa Erika | 3 |
| #10 | Flieger Miroslav | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2006099946A1 | Transdermal therapeutic system | |
| CA2502142A1 | Transdermal therapeutic systems | |
| DE10226459A1 | Use of dopamine partial agonists to treat restless legs syndrome | |
| DE10212564A1 | 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine | |
| DE10043321A1 | Use of a transdermal therapeutic system for the treatment of Parkinson's disease, for the treatment and prevention of premenstrual syndrome and for lactation inhibition |